Wockhardt pharma
Wockhardt Q1 net loss at Rs 16 crore; total income at Rs 769 crore
Wockhardt shareholders reject proposal to raise Rs 1,600 crore from promotor
Wockhardt initiates phase-III clinical study of new antibiotic candidate